Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

511 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
BMAL1 loss in oligodendroglia contributes to abnormal myelination and sleep.
Rojo D, Dal Cengio L, Badner A, Kim S, Sakai N, Greene J, Dierckx T, Mehl LC, Eisinger E, Ransom J, Arellano-Garcia C, Gumma ME, Soyk RL, Lewis CM, Lam M, Weigel MK, Damonte VM, Yalçın B, Jones SE, Ollila HM, Nishino S, Gibson EM. Rojo D, et al. Among authors: nishino s. Neuron. 2023 Nov 15;111(22):3604-3618.e11. doi: 10.1016/j.neuron.2023.08.002. Epub 2023 Aug 31. Neuron. 2023. PMID: 37657440 Free PMC article.
Antisense oligonucleotide therapeutic approach for Timothy syndrome.
Chen X, Birey F, Li MY, Revah O, Levy R, Thete MV, Reis N, Kaganovsky K, Onesto M, Sakai N, Hudacova Z, Hao J, Meng X, Nishino S, Huguenard J, Pașca SP. Chen X, et al. Among authors: nishino s. Nature. 2024 Apr;628(8009):818-825. doi: 10.1038/s41586-024-07310-6. Epub 2024 Apr 24. Nature. 2024. PMID: 38658687 Free PMC article.
The efficacy and safety of lenvatinib plus pembrolizumab in vulnerable patients with metastatic or recurrent endometrial cancer: a single institution experience.
Yunokawa M, Abe A, Wang X, Toyohara Y, Nimura R, Komoto T, Misaka S, Yoshimitsu T, Ikki A, Kamata M, Nishino S, Kanno M, Fusegi A, Netsu S, Aoki Y, Omi M, Tanigawa T, Okamoto S, Nomura H, Kanao H. Yunokawa M, et al. Among authors: nishino s. Int J Clin Oncol. 2024 Dec 6. doi: 10.1007/s10147-024-02667-0. Online ahead of print. Int J Clin Oncol. 2024. PMID: 39641902
NKX3.1 Helps Distinguish Hyalinizing Clear Cell Carcinoma From Other Clear Cell Salivary Gland Neoplasms.
Sakyo A, Ryo E, Nishino S, Kobayashi K, Yoshimoto S, Omura G, Fushimi C, Sakai T, Sakai A, Eguchi K, Takahashi H, Yokoyama K, Honma Y, Mori A, Kato H, Hatano T, Yoshida A, Matsumoto F, Yatabe Y, Mori T. Sakyo A, et al. Among authors: nishino s. Lab Invest. 2024 Nov 29;105(3):102205. doi: 10.1016/j.labinv.2024.102205. Online ahead of print. Lab Invest. 2024. PMID: 39617100
511 results